VISISURE Trademark

Trademark Overview


On Thursday, June 2, 2022, a trademark application was filed for VISISURE with the United States Patent and Trademark Office. The USPTO has given the VISISURE trademark a serial number of 79348313. The federal status of this trademark filing is REGISTERED as of Tuesday, July 18, 2023. This trademark is owned by Novartis AG. The VISISURE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...

Drug delivery devices, namely medical injection devices sold empty for administration of pharmaceutical preparations
visisure

General Information


Serial Number79348313
Word MarkVISISURE
Filing DateThursday, June 2, 2022
Status700 - REGISTERED
Status DateTuesday, July 18, 2023
Registration Number7109893
Registration DateTuesday, July 18, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Goods and ServicesDrug delivery devices, namely medical injection devices sold empty for administration of pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 2, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, November 13, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 19, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 19, 2023FINAL DISPOSITION PROCESSED
Wednesday, October 18, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 18, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, May 17, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 2, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 26, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 6, 2023REFUSAL PROCESSED BY IB
Wednesday, March 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 13, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 13, 2023REFUSAL PROCESSED BY MPU
Thursday, January 19, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 18, 2023NON-FINAL ACTION WRITTEN
Thursday, January 12, 2023NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, November 1, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 31, 2022NON-FINAL ACTION WRITTEN
Monday, October 31, 2022ASSIGNED TO EXAMINER
Saturday, October 1, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, October 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Saturday, October 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, October 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 1, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 6, 2022APPLICATION FILING RECEIPT MAILED
Friday, September 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 30, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 25, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB